Sosei Group Corporation
Research Sosei Group Corporation (JSS) on Bullrun: market cap EUR 486.18M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerJSS
- ExchangeF
- CountryJapan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 486.18M
- Financial periodFY2025
- RevenueEUR 29.62B
- Revenue growth2.7%
- Net income-EUR 12.53B
- Free cash flow-EUR 3.29B
- Gross margin72.3%
Valuation Snapshot
latest market cap is EUR 486.18M.
About Sosei Group Corporation
Nxera Pharma Co., Ltd. operates as a biopharmaceutical company, engages in drug discovery and development in Japan, the United States, Germany, Switzerland, Bermuda, the United Kingdom, and internationally. The company offers NxWave, a GPCR-targeted structure-based drug discovery platform; PIVLAZ for the cerebral vasospasm, vasospasm-related cerebral infarction, and cerebral ischemic symptoms after aSAH; and QUVIVIQ for insomnia.
Frequently asked questions
What is Sosei Group Corporation's market cap?
Sosei Group Corporation's market capitalization is EUR 486.18M.
What does Sosei Group Corporation do?
Nxera Pharma Co., Ltd. operates as a biopharmaceutical company, engages in drug discovery and development in Japan, the United States, Germany, Switzerland, Bermuda, the United Kingdom, and internationally. The company offers NxWave, a GPCR-targeted structure-based drug discovery platform;